Skip to main content

Novartis DRC Basic human research study of novel glaucoma endpoints and identification of optimal patient populations for neuroprotection trials

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Novartis Pharma AG

Start Date

March 18, 2020

End Date

May 30, 2025
 

Administered By

Ophthalmology

Awarded By

Novartis Pharma AG

Start Date

March 18, 2020

End Date

May 30, 2025